4 Heart Attack Clinical Trials in Berkeley, CA (2026)

Q: How do I join a clinical trial in Berkeley?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Berkeley research site will contact you.

Recruiting Heart Attack Studies in Berkeley

NCT06136559Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

The goal of this study is to evaluate nemtabrutinib compared with investigator's choice of ibrutinib or acalabrutinib in participants with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma...

Berkeley, CAPHASE31,200 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05554406Recruiting

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens works to shrink cancer in patients with...

Berkeley, CAPHASE2335 participantsNational Cancer Institute (NCI)

View Study Details

NCT06317649Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit...

Berkeley, CAPHASE2147 participantsNational Cancer Institute (NCI)

View Study Details

NCT06672146Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

This phase II MyeloMATCH treatment trial studies how well ASTX727 and venetoclax plus enasidenib works compared to ASTX727 and venetoclax alone for the treatment of older patients with newly diagnosed...

Berkeley, CAPHASE293 participantsNational Cancer Institute (NCI)

View Study Details

About Heart Attack Clinical Trials in Berkeley

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 4 heart attack clinical trials recruiting participants in Berkeley, CA. These studies are seeking a combined 1,775 participants. Research is being sponsored by Merck Sharp & Dohme LLC, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Berkeley — FAQ

Are there heart attack clinical trials in Berkeley?

Yes, there are 4 heart attack clinical trials currently recruiting in Berkeley, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Berkeley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Berkeley research site will contact you about next steps.

Are clinical trials in Berkeley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Berkeley studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 4 active trials in Berkeley are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 22, 2026 from ClinicalTrials.gov